Filing Details

Accession Number:
0001209191-19-042266
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-16 18:05:15
Reporting Period:
2019-07-12
Accepted Time:
2019-07-16 18:05:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1716621 Ra Medical Systems Inc. RMED Surgical & Medical Instruments & Apparatus (3841) 383661826
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746687 Dean Irwin C/O Ra Medical Systems, Inc.
2070 Las Palmas Drive
Carlsbad CA 92011
See Remarks Yes Yes Yes No
1748379 Dean Irwin & Melissa Burstein, As Trustees U/T/A June 12, 2017 C/O Ra Medical Systems, Inc.
2070 Las Palmas Drive
Carlsbad CA 92011
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-07-12 7,400 $3.27 213,812 No 4 S Direct
Common Stock Disposition 2019-07-12 4,400 $3.28 128,438 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,803,852 Indirect See Footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on September 27, 2018.
  2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Of the reported shares 173,670 shares are represented by Restricted Stock Units.
  4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. Of the reported shares 104,202 shares are represented by Restricted Stock Units.
  6. Shares held of record by Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017, of which Dean Irwin serves as co-trustee.